A 42-year-old woman presents with 6 months of early morning joint stiffness lasting 90 minutes, symmetrical swelling of the metacarpophalangeal and proximal interphalangeal joints and positive anti-CCP antibodies. X-rays show no erosions. What is the most appropriate initial disease-modifying pharmacological treatment?